Compound’s covenant compliance model of Westrock Coffee Company puts the borrower’s thinnest cushion at March 31, 2027, the second test date under its new credit agreement. Projected secured net leverage there is 4.20x against a 4.50x maximum, a headroom of 6.7%: covenant EBITDA could fall about $5.7 million before a breach. The model rates the credit 4, Watchlist – elevated, on a 1 to 5 scale it sets out on its own sheet. On the latest actual test date, September 30, 2026, headroom was 23.1%.
The tightening comes from the model’s projection, and it is the model’s result under its assumptions, not a view on Westrock’s credit. Two things drive it: trailing covenant EBITDA under the new agreement’s definition falls from $90.0 million to $85.0 million as start-up add-backs roll out of the window, and secured net debt rises from $286 million to $357 million through the refinancing and the cash outflows management flagged for the fourth and first quarters. At the low end of guidance, March 31, 2027 is a breach at 4.63x.
You are on the portfolio monitoring team of a credit fund that holds leveraged loans. Each quarter you need covenant EBITDA as the agreement defines it, the ratios against their levels, the EBITDA cushion, and the tightest quarter ahead. We asked Compound to do that work on a real borrower from public filings. It ran on November 19, 2026 and returned one Excel workbook of six sheets and a short written answer.
What the workbook shows:
- The facility. Westrock Beverage Solutions, LLC borrows a $300 million term loan and a $300 million revolver under a credit agreement dated October 21, 2026. Maximum secured net leverage is 4.50x, stepping down to 4.25x for test periods after June 30, 2027 and 4.00x after June 30, 2028. Minimum fixed charge coverage is 1.20x. Both are first tested at December 31, 2026.
- The history. Eight test dates from December 31, 2024 to September 30, 2026, tested under the prior credit agreement at the levels then in force. Headroom ran from 11.6% at March 31, 2025 to 34.3% at March 31, 2026, and the computed ratio is within 0.005x of the reported one at every date.
- The projection. Leverage of 3.95x, 4.20x, 3.73x and 3.29x at the four test dates to September 30, 2027. The step-down to 4.25x is cleared, at 3.29x. Fixed charge coverage stays between 1.83x and 2.29x.
- The flags. Headroom below 15% at one actual date and two projected dates. No step-down missed. No quarter where covenant EBITDA rose while reported EBITDA fell.
The covenants, the agreement’s fixed figures for five past quarters, the eight quarters of EBITDA reconciliations, segment results and the company’s own covenant calculation come from Westrock’s filings on SEC EDGAR. Guidance comes from the third-quarter 2026 earnings release and the earnings call of November 5, 2026. Interest is priced off the SOFR forward curve, computed from SOFR published by the Federal Reserve Bank of New York. The Sources sheet notes that no web search was needed. Every other input is marked “Analyst assumption” with a reason.
“I monitor a portfolio of leveraged loans and want the quarterly covenant compliance work done on a real borrower. From SEC EDGAR, pick one U.S. public company whose credit agreement filed as an exhibit has a maintenance financial covenant, such as a maximum net leverage ratio or a minimum fixed charge coverage ratio, and whose 10-Q says whether it complied. From the credit agreement, take the covenant definitions, levels and step-downs by test date. From the last eight 10-Qs and 10-Ks, build trailing-twelve-month Consolidated EBITDA as the agreement defines it, the debt and fixed charges it counts, and each covenant ratio by quarter, next to what the company reports where it does. Show headroom each quarter as the EBITDA cushion, the percent EBITDA could fall before a breach, and the trend against the prior quarter and the same quarter last year. Project the next four quarters from guidance or the latest earnings call, with the scheduled step-downs, and find the quarter the cushion is thinnest. Assign an internal risk rating from 1 to 5 with the criteria on the sheet, and write a watchlist call with what would move the rating. Flag headroom below 15%, a step-down the projection does not clear, and any quarter where the covenant EBITDA rises while reported EBITDA falls. Use the stored public data wherever it has the figure, and web search only for what it lacks. Put every input on an Assumptions sheet with one column that says where it came from: a cited source, or "analyst assumption" for a figure I would set myself, with the reason for the value you chose. Every output must be a live formula that traces back to the Assumptions sheet. Add a Sources sheet listing each data source, what it gave and its date. Deliver one Excel workbook and a short summary of the result, the flags, and what I would need from the borrower's compliance certificate to firm it up. Cite every sourced figure.”
That is the request as we sent it, without its closing line, which asks that no name or email be put in the workbook.
Choosing the borrower and reading the credit agreement
Compound chose Westrock Coffee, whose new credit agreement is filed as Exhibit 10.1 to an 8-K and whose 10-Qs disclose the secured net leverage calculation and state compliance every quarter. The covenant levels, the add-back caps, the equity cure limit and five quarters of fixed EBITDA all come from that agreement.
The borrower is Westrock Beverage Solutions, LLC, which the model treats as the Beverage Solutions segment. The sourcing segment, SS&T, sits outside the borrower group, so its EBITDA comes out of covenant EBITDA. The agreement closed on October 21, 2026, and the press release that day gave $40 million of unrestricted cash and $230 million of undrawn revolver at closing.
| B | C | D | |
|---|---|---|---|
| 6 | Input | Unit | Value |
| 8 | Term loan – initial principal | $M | 300.0 |
| 9 | Revolving credit commitments | $M | 300.0 |
| 10 | Maximum secured net leverage – test periods ending on or before step-down date 1 | x | 4.50x |
| 11 | Step-down date 1 (applies to test periods ending after) | date | 6/30/2027 |
| 12 | Maximum secured net leverage – after step-down date 1 | x | 4.25x |
| 13 | Step-down date 2 (applies to test periods ending after) | date | 6/30/2028 |
| 14 | Maximum secured net leverage – after step-down date 2 | x | 4.00x |
| 15 | Minimum fixed charge coverage ratio | x | 1.20x |
| 17 | Cap on Projected Savings + pro forma adjustments to 31-Dec-2026 (% of EBITDA after them) | % | 15.0% |
| 18 | Aggregate Adjustment Cap on capped add-backs (% of EBITDA before them) | % | 25.0% |
| 19 | Aggregate Adjustment Cap applies to test periods ending on or after | date | 3/31/2027 |
| 21 | Applicable margin – Term SOFR loans (initial; grid 2.50%-4.00%) | % | 3.50% |
| 23 | Scheduled term loan amortization, year 1 (% of original principal per year) | % | 2.500% |
| 33 | Maximum equity cures (Specified Equity Contributions) over the facility life | # | 5 |
Add-backs are capped: projected savings and pro forma adjustments at 15% of EBITDA for test periods to December 31, 2026, then an Aggregate Adjustment Cap of 25% on restructuring, start-up and savings add-backs from March 31, 2027. A Step-Up Election can raise the leverage maximum after a specified acquisition, and up to five Specified Equity Contributions can cure a miss.
The term that matters most for the projection: the agreement fixes Adjusted Consolidated EBITDA, the fixed charge coverage numerator and Consolidated Fixed Charges for each quarter from September 30, 2025 to September 30, 2026, in whole dollars: $23,511,909 of EBITDA for the September 2026 quarter, for example. The first four test periods are therefore built mostly from numbers the lenders and the borrower agreed in advance.
Rebuilding covenant EBITDA from net income
The model starts from consolidated net income and adds back each line of the company’s EBITDA reconciliation, mapped to a clause of the definition. It ties to reported EBITDA and to both segment EBITDA figures in every quarter.
| B | J | K | L | M | N | |
|---|---|---|---|---|---|---|
| 6 | ($000) | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
| 17 | (+) Conway facility pre-production costs | 5,246 | 5,959 | 278 | 49 | – |
| 18 | (+) Conway facility scale-up operating costs | 3,018 | 1,375 | 3,766 | 2,829 | – |
| 22 | Total Segment Adjusted EBITDA ($000) | 26,177 | 24,331 | 29,734 | 24,126 | 26,411 |
| 24 | (-) SS&T Segment Adjusted EBITDA | 5,755 | 5,525 | 6,460 | 1,959 | 3,154 |
| 25 | Beverage Solutions Segment Adjusted EBITDA ($000) | 20,422 | 18,806 | 23,274 | 22,167 | 23,257 |
| 27 | Memo: capped add-backs in the quarter (rows 13, 17, 18) | 11,293 | 9,512 | 7,712 | 6,046 | 3,790 |
| 28 | Memo: capped add-backs as % of Beverage Solutions Segment Adj. EBITDA | 55.3% | 50.6% | 33.1% | 27.3% | 16.3% |
The lines that matter are the start-up costs of the Conway facility. Pre-production costs and scale-up operating costs were large add-backs through 2025, and the segment note shows the company stopped adding back scale-up costs from the September 2026 quarter. Compound’s note beside the row records it, and the earnings call confirms it: “Beginning in the third quarter, we no longer add back Conway’s subscale operating costs in calculating Beverage Solutions segment adjusted EBITDA.”
The memo rows show what that does to earnings quality. Capped add-backs were 118.1% of Beverage Solutions segment EBITDA in the March 2024 quarter, 55.3% in September 2025 and 16.3% in September 2026. The September 2026 figure is the restructuring and integration line alone.
December quarters are derived as the 10-K’s full year less the nine months in the third-quarter 10-Q.
Eight quarters as tested under the prior agreement
At each of the eight past test dates, the model tests the covenant that was then in force: the prior agreement’s secured net leverage maximum, from 6.00x down to 4.00x as its relief period ended. The computed ratio matches the reported one within 0.005x at every date, and the company stated compliance at every date.
| B | G | H | I | J | K | L | M | N | |
|---|---|---|---|---|---|---|---|---|---|
| 31 | ($000) | 12/31/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
| 32 | TTM Beverage Solutions Segment Adjusted EBITDA (built) | 53,639 | 52,422 | 58,847 | 67,517 | 68,481 | 82,172 | 84,669 | 87,504 |
| 34 | (+) Permissible credit agreement adjustments (run-rate cost savings) | 9,126 | 7,858 | 11,137 | 8,612 | 6,668 | 12,527 | 8,505 | 5,538 |
| 35 | Covenant EBITDA – Credit Agreement Adjusted EBITDA ($000) | 62,765 | 60,280 | 69,984 | 76,129 | 75,149 | 94,699 | 93,174 | 93,042 |
| 41 | Secured debt ($000) | 318,498 | 350,685 | 372,873 | 379,480 | 337,762 | 353,543 | 349,324 | 325,105 |
| 42 | (-) Beverage Solutions unrestricted cash | (22,917) | (30,798) | (40,707) | (31,134) | (48,232) | (26,771) | (36,177) | (39,011) |
| 43 | Secured net debt ($000) | 295,581 | 319,887 | 332,166 | 348,346 | 289,530 | 326,772 | 313,147 | 286,094 |
| 44 | Secured net leverage ratio – computed (x) | 4.71x | 5.31x | 4.75x | 4.58x | 3.85x | 3.45x | 3.36x | 3.07x |
| 45 | Secured net leverage ratio – reported (x) | 4.71x | 5.31x | 4.75x | 4.58x | 3.85x | 3.45x | 3.36x | 3.07x |
| 47 | Maximum permitted (x) | 6.00x | 6.00x | 6.00x | 5.50x | 5.50x | 5.25x | 4.00x | 4.00x |
| 51 | EBITDA cushion ($000) | 13,502 | 6,966 | 14,623 | 12,793 | 22,507 | 32,457 | 14,887 | 21,519 |
| 52 | % EBITDA could fall before breach | 21.5% | 11.6% | 20.9% | 16.8% | 30.0% | 34.3% | 16.0% | 23.1% |
The rebuild works on the prior agreement’s own terms. Trailing Beverage Solutions segment EBITDA is the sum of four built quarters. On top of it the model adds the line the company’s covenant table calls permissible credit agreement adjustments, mainly run-rate cost savings, which is taken as reported: $5,538 thousand at September 30, 2026. Secured debt is the term loan, the delayed draw term loan, the revolver and letters of credit as the company lists them, less Beverage Solutions unrestricted cash.
Because the savings line and the debt come from the company’s table, the 0.005x match confirms the EBITDA build, not an independent reading of the old agreement. The prior agreement’s minimum interest coverage, 1.50x and then 1.75x, was never disclosed as a ratio, so the model carries it as a memo line.
Secured net leverage headroom by test date
Percent covenant EBITDA could fall before a breach. Dec-24 to Sep-26 actual under the prior agreement; Dec-26 to Sep-27 projected under the new one
Compound's Summary tab, covenant dashboard: the Hist_Covenant tab for the actual dates and the Projection tab for the projected ones.
The trend rows answer the request’s prior-quarter and same-quarter-last-year comparisons. The sharpest quarterly fall was June 30, 2026, down 18.3 points as the maximum dropped from 5.25x to 4.00x. The prior agreement’s covenant relief period ended early, which the 10-Q for that quarter reports. Year on year, headroom rose at three of the four dates where a comparison exists (our count). The model leaves the first four year-on-year cells as “n/a”, because the company first disclosed the calculation in its 10-K for fiscal 2024.
The one actual flag is March 31, 2025: 5.31x against 6.00x, a $6,966 thousand cushion.
The same history on the new agreement’s terms
The model also restates all eight dates on the new agreement’s definition, with no level to test them against: the new covenants did not exist yet. On that basis the September 30, 2026 ratio is 3.18x instead of 3.07x, and the gap comes from the prior agreement’s run-rate savings line, which is larger than the adjustments the new agreement deems.
| B | G | H | I | J | K | L | M | N | |
|---|---|---|---|---|---|---|---|---|---|
| 77 | ($000) | 12/31/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
| 78 | Adjusted Consolidated EBITDA – quarterly, new definition | 17,842 | 9,583 | 19,670 | 20,677 | 19,761 | 24,243 | 22,477 | 23,512 |
| 79 | Pro forma adjustment vs Beverage Solutions Segment Adj. EBITDA | – | – | – | 255 | 955 | 969 | 310 | 255 |
| 80 | TTM Adjusted Consolidated EBITDA – new definition ($000) | 53,639 | 52,422 | 58,847 | 67,772 | 69,691 | 84,351 | 87,157 | 89,993 |
| 81 | Secured net debt ($000) | 295,581 | 319,887 | 332,166 | 348,346 | 289,530 | 326,772 | 313,147 | 286,094 |
| 82 | Secured net leverage ratio – new definition (x) | 5.51x | 6.10x | 5.64x | 5.14x | 4.15x | 3.87x | 3.59x | 3.18x |
| 83 | Difference vs as-tested ratio (x) | 0.801x | 0.795x | 0.898x | 0.564x | 0.302x | 0.423x | 0.232x | 0.104x |
Section D works like this. For the quarters before September 2025, new-definition EBITDA is Beverage Solutions segment EBITDA with no adjustment. From September 2025 it is the amount the agreement deems for each quarter, which runs $254.7 thousand to $969.0 thousand above the segment figure. The trailing sum is set against the same secured net debt as the as-tested calculation. The model labels the result “pro forma history (covenants first tested 31-Dec-2026)” and draws no flag from it.
The restatement explains the projection. The new definition gives $89,993 thousand at September 30, 2026, against $93,042 thousand as tested under the old agreement, so the borrower starts the new facility with less covenant EBITDA than its last reported calculation showed.
Set against the new 4.50x maximum, the first four restated dates would sit above it, at 5.51x, 6.10x, 5.64x and 5.14x, and the last four below it (our comparison). The model does not make that test, and the comparison describes a covenant the borrower was not subject to.
The same section builds a pro forma fixed charge coverage ratio at June 30 and September 30, 2026 from the deemed numerator and fixed charges: 1.61x and 1.77x, marked “Not tested”. Four deemed quarters are needed, so the series starts at June 2026.
Covenant EBITDA against reported EBITDA
The divergence flag never trips. Over the eight dates the pattern ran the other way: reported EBITDA climbed from a loss as the add-backs shrank, and covenant EBITDA fell in four quarters where reported EBITDA rose (our count).
| B | G | H | I | J | K | L | M | N | |
|---|---|---|---|---|---|---|---|---|---|
| 64 | ($000) | 12/31/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
| 65 | TTM EBITDA – reported basis ($000) | (7,969) | (6,274) | 6,911 | 15,213 | 19,390 | 43,948 | 53,783 | 64,702 |
| 66 | TTM covenant EBITDA ($000) | 62,765 | 60,280 | 69,984 | 76,129 | 75,149 | 94,699 | 93,174 | 93,042 |
| 67 | Add-backs included in covenant EBITDA ($000) | 70,734 | 66,554 | 63,073 | 60,916 | 55,759 | 50,751 | 39,391 | 28,340 |
| 68 | Add-backs as % of covenant EBITDA | 112.7% | 110.4% | 90.1% | 80.0% | 74.2% | 53.6% | 42.3% | 30.5% |
| 69 | Covenant EBITDA change vs prior quarter ($000) | n/a | (2,485) | 9,704 | 6,145 | (980) | 19,550 | (1,525) | (132) |
| 70 | Reported EBITDA change vs prior quarter ($000) | n/a | 1,695 | 13,185 | 8,302 | 4,177 | 24,558 | 9,835 | 10,919 |
| 71 | FLAG – covenant EBITDA up while reported EBITDA down (vs prior quarter) | – | – | – | – | – | – | – | – |
Trailing reported EBITDA went from a loss of $7,969 thousand at December 31, 2024 to $64,702 thousand at September 30, 2026. Over the same span add-backs fell from 112.7% to 30.5% of covenant EBITDA. The quarters where covenant EBITDA fell while reported EBITDA rose are March 2025, December 2025, June 2026 and September 2026. More of the covenant figure is earned rather than added back.
The model runs the test quarter on quarter and year on year, and finds nothing to count. It cannot run on the projection, because the model does not project reported EBITDA.
Projecting the next four test dates
The projection takes the midpoint of 2026 guidance and the preliminary 2027 guidance, removes SS&T, and adds $0.55 million a quarter of savings. Trailing covenant EBITDA falls to $85,028 thousand at March 31, 2027 because the projected December and March quarters replace larger deemed quarters, then recovers to $100,026 thousand by September 30, 2027.
| B | E | F | G | H | I | J | K | |
|---|---|---|---|---|---|---|---|---|
| 14 | ($000) | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/31/2026 | 3/31/2027 | 6/30/2027 | 9/30/2027 |
| 15 | Consolidated Adjusted EBITDA | 25,968 | 21,297 | 26,411 | 21,324 | 28,600 | 31,200 | 33,800 |
| 16 | (+) Conway scale-up add-back (segment basis) | 3,766 | 2,829 | – | ||||
| 17 | (-) SS&T Segment Adjusted EBITDA | 6,460 | 1,959 | 3,154 | 5,525 | 6,460 | 1,959 | 3,154 |
| 18 | Beverage Solutions Segment Adjusted EBITDA | 23,274 | 22,167 | 23,257 | 15,799 | 22,140 | 29,241 | 30,646 |
| 20 | (+) Pro forma adjustments / Projected Savings | 969 | 310 | 255 | 550 | 550 | 550 | 550 |
| 21 | Adjusted Consolidated EBITDA – quarterly ($000) | 24,243 | 22,477 | 23,512 | 16,349 | 22,690 | 29,791 | 31,196 |
| 22 | TTM Adjusted Consolidated EBITDA before caps | 89,993 | 86,581 | 85,028 | 92,342 | 100,026 | ||
| 25 | Aggregate Adjustment Cap applies? | No | No | Yes | Yes | Yes | ||
| 27 | (-) Excess disallowed – Aggregate Adjustment Cap | – | – | – | – | – | ||
| 31 | TTM covenant EBITDA after caps ($000) | 89,993 | 86,581 | 85,028 | 92,342 | 100,026 |
Guidance for 2026 is $90.0 million to $100.0 million of Consolidated Adjusted EBITDA, and the model takes the midpoint because management said its estimate is in the middle of the range. With $73,676 thousand earned in the nine months, the December 2026 quarter is $21,324 thousand, 7.1% below the December 2025 quarter. 2027 guidance is about $130.0 million, and the model spreads it 22%, 24% and 26% over the first three quarters, weighted to the second half because new programs launch mid to late 2027.
SS&T is held flat on the same quarter a year earlier. The December quarter’s covenant EBITDA of $16,349 thousand then replaces the deemed $19,761 thousand of December 2025, and March’s $22,690 thousand replaces $24,243 thousand: $3,412 thousand and $1,553 thousand off the trailing figure (our arithmetic). The Aggregate Adjustment Cap applies from March 31, 2027, and the $3.5 million a quarter of restructuring add-backs the model assumes stays under it at every date. The model’s note explains why: the deemed quarters are fixed “notwithstanding” the caps, so only new quarters count toward them.
The debt side moves the ratio more than EBITDA does.
Secured net debt from September 30, 2026 to March 31, 2027
US$ thousands. The refinancing step includes $20.7 million paid to repurchase convertible notes
Compound's Projection tab, section C. Closing cash and undrawn revolver: Westrock's Form 8-K of October 21, 2026, Exhibit 99.1.
At closing, the model sets secured net debt at $330,000 thousand: the $300 million term loan plus $300 million of revolver commitments, less $40 million of cash and $230 million undrawn. That is $43,906 thousand above the September 30 figure, including the $20.7 million paid for the convertible note repurchase. After closing, the changes are analyst assumptions tied to the call, where management said leverage would “temporarily increase by about half a turn in the fourth quarter and another quarter to half turn in the first quarter of next year” as incentive pay and tariff refunds go out: +$12 million and +$15 million, then −$13 million and −$15 million as EBITDA ramps.
| B | G | H | I | J | K | |
|---|---|---|---|---|---|---|
| 51 | ($000) | 9/30/2026 | 12/31/2026 | 3/31/2027 | 6/30/2027 | 9/30/2027 |
| 52 | Covenant EBITDA – TTM ($000) | 93,042 | 86,581 | 85,028 | 92,342 | 100,026 |
| 53 | Secured net debt ($000) | 286,094 | 342,000 | 357,000 | 344,000 | 329,000 |
| 54 | Secured net leverage ratio (x) | 3.07x | 3.95x | 4.20x | 3.73x | 3.29x |
| 55 | Maximum permitted (x) | 4.00x | 4.50x | 4.50x | 4.50x | 4.25x |
| 57 | Minimum covenant EBITDA to comply ($000) | 71,524 | 76,000 | 79,333 | 76,444 | 77,412 |
| 58 | EBITDA cushion ($000) | 21,519 | 10,581 | 5,694 | 15,897 | 22,614 |
| 59 | % EBITDA could fall before breach | 23.1% | 12.2% | 6.7% | 17.2% | 22.6% |
| 60 | Ratio cushion (turns) | 0.93x | 0.55x | 0.30x | 0.77x | 0.96x |
| 66 | Headroom against the next scheduled maximum (%) | 7.1% | 1.2% | 12.3% | 17.8% | |
| 67 | FLAG – headroom below threshold | – | FLAG | FLAG | – | – |
The minimum covenant EBITDA at March 31, 2027 is $79,333 thousand, and the projection has $85,028 thousand, so the cushion is $5,694 thousand. In turns, leverage is 0.30x below the maximum. The sheet also tests each quarter against the next maximum: March’s 4.20x would clear the 4.25x level due from September by 1.2%.
The year-on-year rows compare new-agreement tests with the prior agreement a year earlier, as the model’s note says, so the 27.6-point fall at March 31, 2027 partly reflects the old relief levels.
Fixed charge coverage is not the binding test. Cash interest is three-month forward SOFR of 4.2% to 4.7% plus the 3.50% initial margin on the term loan and an implied revolver draw, plus convertible note interest and 2.5% annual amortization.
| B | H | I | J | K | |
|---|---|---|---|---|---|
| 72 | ($000) | 12/31/2026 | 3/31/2027 | 6/30/2027 | 9/30/2027 |
| 75 | TTM FCCR numerator: covenant EBITDA less cash taxes and Maintenance Capex ($000) | 84,756 | 83,988 | 90,846 | 96,026 |
| 79 | Cash interest on term loan and revolver | 7,201 | 7,572 | 7,835 | 7,651 |
| 80 | Commitment fee on undrawn revolver | 196 | 183 | 181 | 191 |
| 81 | Distributions to fund convertible note interest | 855 | 855 | 855 | 855 |
| 83 | Scheduled term loan amortization | 1,875 | 1,875 | 1,875 | 1,875 |
| 84 | Consolidated Fixed Charges – quarterly ($000) | 10,127 | 10,486 | 10,746 | 10,572 |
| 85 | TTM Consolidated Fixed Charges ($000) | 46,204 | 44,248 | 43,010 | 41,930 |
| 86 | Fixed charge coverage ratio (x) | 1.83x | 1.90x | 2.11x | 2.29x |
| 87 | Minimum required (x) | 1.20x | 1.20x | 1.20x | 1.20x |
| 90 | % EBITDA could fall before breach | 33.9% | 36.3% | 42.5% | 45.7% |
The ratio is 1.83x at December 31, 2026 and 1.90x at March 31, 2027, with 33.9% and 36.3% of EBITDA headroom. Three of the four quarters in the December trailing figure, and two in March, are fixed charges deemed by the agreement.
Guidance sensitivity and the risk rating
The rating is set by the thinnest projected headroom: 6.7% falls in the 5% to 15% band, so the credit is a 4. A switch on the Assumptions sheet runs the low and high ends of guidance on the same debt path, and the low end breaches at March 31, 2027.
| B | D | E | F | |
|---|---|---|---|---|
| 114 | ($000) | Low end | Midpoint | High end |
| 115 | FY2026 Consolidated Adj. EBITDA | 90,000 | 95,000 | 100,000 |
| 116 | FY2027 Consolidated Adj. EBITDA | 117,000 | 130,000 | 143,000 |
| 117 | Dec-26 quarter covenant EBITDA | 11,349 | 16,349 | 21,349 |
| 118 | Mar-27 quarter covenant EBITDA | 19,830 | 22,690 | 25,550 |
| 119 | TTM covenant EBITDA – Dec-26 | 81,581 | 86,581 | 91,581 |
| 120 | TTM covenant EBITDA – Mar-27 (after Aggregate Adjustment Cap) | 77,168 | 85,028 | 92,888 |
| 121 | Secured net leverage – Dec-26 (x) | 4.19x | 3.95x | 3.73x |
| 122 | Secured net leverage – Mar-27 (x) | 4.63x | 4.20x | 3.84x |
| 123 | % EBITDA could fall before breach – Dec-26 | 6.8% | 12.2% | 17.0% |
| 124 | % EBITDA could fall before breach – Mar-27 | (2.8%) | 6.7% | 14.6% |
| 125 | Mar-27 covenant status | Breach | Compliant | Compliant |
The low case takes $90.0 million for 2026 and 2027 guidance 10% lower, at $117,000 thousand. Trailing covenant EBITDA at March 31, 2027 is then $77,168 thousand and leverage 4.63x. The high case gives 3.84x and 14.6% headroom, still below the 15% flag.
| B | C | D | E | |
|---|---|---|---|---|
| 6 | Rating | Label | Headroom at least | Headroom below |
| 7 | 1 | Strong | 35% | – |
| 8 | 2 | Satisfactory | 25% | 35% |
| 9 | 3 | Watch | 15% | 25% |
| 10 | 4 | Watchlist – elevated | 5% | 15% |
| 11 | 5 | Critical | – | 5% |
The bands are analyst assumptions. Notch-downs for a missed step-down and for add-back-driven growth at two or more of the last four dates do not apply, so the rating stays at 4.
| B | D | |
|---|---|---|
| 100 | Thinnest projected cushion (%) | 6.7% |
| 101 | Test date of the thinnest cushion | 3/31/2027 |
| 102 | Binding covenant at that date | Leverage |
| 103 | EBITDA cushion at that date ($000) | 5,694 |
| 104 | Projected covenant tests with headroom below threshold (#) | 2 |
| 105 | Projected step-downs not cleared (#) | 0 |
| 106 | Projected TTM covenant EBITDA at that date ($000) | 85,028 |
| 107 | TTM covenant EBITDA at breach, 0% headroom ($000) | 79,333 |
| 108 | TTM covenant EBITDA needed for headroom at the flag threshold ($000) | 93,333 |
| 109 | Secured net debt at that date ($000) | 357,000 |
| 110 | Maximum secured net debt for headroom at the flag threshold ($000) | 325,231 |
| 111 | TTM covenant EBITDA at the rating-5 boundary ($000) | 83,509 |
The watchlist call on the Rating sheet sets out what moves the rating. It goes to 3 if trailing covenant EBITDA at March 31, 2027 reaches $93.3 million against the $85.0 million projected, or if secured net debt stays at or below $325.2 million against $357.0 million. It goes to 5 below $83.5 million, and $79.3 million is a breach. The mitigants it lists are $241 million of projected liquidity at March 31, 2027, the 36% fixed charge coverage cushion, the five equity cures, and the 2027 guidance that takes leverage to 3.29x by September.
What the public filings cannot tell you
The 10-Q gives the company’s own ratio under the old agreement, and the new agreement fixes five quarters of EBITDA. Everything from December 2026 on depends on figures only the compliance certificate will show. Compound’s answer lists what to ask for, and each item replaces an assumption in the model.
From the December 2026 compliance certificate:
- The EBITDA bridge by clause from Consolidated Net Income, split between the borrower group and SS&T, with the 15% and 25% cap calculations.
- Each projected cost saving: amount, timing and how much is already realized.
- Secured debt by instrument, including letters of credit and finance leases, and unrestricted cash by account. This replaces the net debt path.
- Fixed charges: cash interest, including distributions for convertible note interest, scheduled amortization, cash taxes, and maintenance capex split from growth capex.
- How the deemed quarters are treated under the Aggregate Adjustment Cap, and any Step-Up Election, permitted acquisition or equity cure.
- For the prior agreement, the interest coverage ratio actually tested at each quarter. Compliance was stated, but the ratio was never disclosed.
Our view
The work is the quarterly monitoring package we would want: the old covenant tested at the levels in force, the history restated on the new definition, and a projection that finds the tight quarter before the first certificate arrives. We would put the credit on the watchlist on this model and spend the next quarter on net debt.
Under its assumptions the model shows earnings improving while the covenant cushion narrows: add-backs fell to 30.5% of covenant EBITDA, but the refinancing added debt and the new definition starts lower than the old calculation. These are the model’s results, not a view on Westrock’s credit.
The other side is that the tight quarter rests on assumptions the borrower controls or can explain. The +$15 million of net debt in the March quarter is an analyst figure set from management’s half-turn comment, and the $325.2 million threshold for a 3 rating is $31.8 million below the projected $357.0 million (our arithmetic). Liquidity of $241 million and five equity cures also stand between a thin cushion and a default.
Three findings would change our view: a December 2026 quarter below the $15.8 million of Beverage Solutions EBITDA the guidance midpoint implies, March 2027 net debt above the projected path, and add-backs that start to press on the 25% cap. From here the work is a credit agreement analysis of the full EBITDA definition and a credit memo that carries the watchlist call.
Westrock covenant compliance model (Excel)Compound’s workbook from this run: a Summary dashboard with the flags, an Assumptions sheet with a source or reason beside every input, the historical covenant build, the four-quarter Projection with a guidance switch, the Rating criteria and watchlist call, and Sources.Download · FreeFAQ
How is leverage covenant headroom measured as an EBITDA cushion?
Divide secured net debt by the maximum ratio to get the minimum covenant EBITDA that complies, then subtract it from the borrower’s covenant EBITDA. The cushion as a percent of covenant EBITDA is how far earnings can fall before a breach. At March 31, 2027 the model has $357.0 million of net debt over 4.50x, a $79.3 million minimum, and a 6.7% cushion.
How do you test history against a credit agreement that was signed after it?
Test each past date against the covenant then in force, using the borrower’s own disclosed calculation where it gives one. Then restate the history on the new definition for comparison only, without testing it against the new levels. Westrock’s model does both, and the restatement puts September 30, 2026 at 3.18x on the new definition against the 3.07x reported.
What are deemed EBITDA quarters in a credit agreement?
They are fixed amounts the agreement sets for quarters before closing, so the first test periods do not depend on recomputing old results under the new definition. Westrock’s agreement fixes EBITDA, the coverage numerator and fixed charges for five quarters to September 30, 2026. The model’s note treats them as outside the add-back caps.
Why flag covenant EBITDA rising while reported EBITDA falls?
It shows earnings growth that exists only in add-backs, such as projected savings or start-up costs. Westrock shows the opposite: covenant EBITDA fell in four quarters where reported EBITDA rose, as Conway start-up add-backs wound down. The model would notch the rating down after two such quarters in the last four.





